Anti-tumor activity of BDTX-1535, an irreversible CNS penetrant inhibitor of multiple EGFR extracellular domain alterations, in preclinical glioblastoma models

BDTX-1535 - Black Diamond Therap

M. Lucas1; M. Merchant2; M. O'Connor3; S. Smith4; A. Trombino4; N. Waters4; S. Eathiraj2; J. Ball5; A. Breschi5; K. Igartua5; M. Kang5; E. Buck6

Sep 3, 2022